Astellas Gene Therapies

📍 San Francisco, United States👥 406 employees💰 Last funded Jul 2017
Biotechnology Research🌐 astellasgenetherapies.com
Website LinkedIn
Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina. Content is intended for a US audience.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Astellas Gene Therapies?
Astellas Gene Therapies has 1 investors on record on gritt.io, 1 mid-stage.
When did Astellas Gene Therapies last raise funding?
The most recent investment in Astellas Gene Therapies recorded on gritt.io was in July 2017.
What industry is Astellas Gene Therapies in?
Astellas Gene Therapies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Astellas Gene Therapies based?
Astellas Gene Therapies is headquartered in San Francisco, United States.